Enovis Corporation (ENOV) has a MoatMap StockRank of 59/100 based on Quality (42/100), Value (56/100), and Momentum (45/100) factor scores. The current signal is HOLD. Enovis Corporation, a US healthcare (medical technology) company, has an extremely poor 'SR: 14.8' (composite) score and a 'STRONG_SELL' signal. Its 'Q: 20' (quality) score is terrible, immediately failing the Terry Smith quality filter. There is no clear asymmetric macro tailwind to justify any consideration for a high-conviction fund.
Enovis Corporation is a global medical technology company dedicated to advancing musculoskeletal care through its diverse portfolio of orthopedic rehabilitation, surgical, and preventative solutions. Its competitive advantage stems from a broad product range spanning joint reconstruction, bracing, and surgical technologies, supported by established distribution channels and a focus on innovation. Enovis maintains a significant presence in the orthopedic market, addressing patient needs from injury prevention to recovery.
| Price | $25.57 |
| Market Cap | $1.4B |
| P/E (Forward) | 6.33 |
| Price/Book | 1.00 |
| Return on Equity | -55.3% |
| Return on Invested Capital | -34.7% |
| Debt/Equity | 95.34 |
| Gross Margin | 61.0% |
| Operating Margin | 3.6% |
| Revenue Growth | 5.4% |
| Free Cash Flow | $207M |
Enovis Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).